Key facts
- Notable investors include Leibniz Institute For Science And Mathematics Education, Mittelständische Beteiligungsgesellschaft Thüringen, RWTH Innovation, Science4Life, Sparkasse Jena — 8 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for DeepEn (Biotechnology)
- ·The full record, as it builds
Funding rounds
No funding rounds for DeepEn (Biotechnology) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About DeepEn (Biotechnology)
Operator of a biotechnology company intended to develop hair-thin microendoscopes. The company's microendoscopes offer quality images from inside sensitive and dynamic environments for redefining the possibilities of bioimaging, enabling clients to increase their understanding of diseases and microscopic processes deep inside sensitive tissues.
- Sector
- Healthcare
- HQ
- Jena, Germany
- Founded
- 2022
- Employees
- 7
- Website
- deepen-imaging.com/
- Ownership
- Privately Held (backing)
DeepEn (Biotechnology) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in DeepEn (Biotechnology) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on DeepEn (Biotechnology) in its N-PORT filings yet. We sweep new filings monthly.